CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Cannabis Bioscience International Holdings, Inc.
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026
- Market cap
- $2.33M
- P/E (TTM)
- –
- Dividend yield
- –
Cannabis Bioscience International statistics
Financials through Feb 28, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison
Valuation
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Market Cap | $2.33M | $73.61M |
| Enterprise Value | $2.59M | $55.54M |
| PS Ratio | 18.81 | 3.25 |
Enterprise value
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| EV / Sales | 20.94 | 2.79 |
Income (trailing twelve months)
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Revenue | $123.63K | $24.74M |
| Gross Profit | $97.39K | $19.54M |
| Operating Income | -$398.82K | -$55.64K |
| Net Income | -$515.29K | -$97.64K |
| EBITDA | -$398.82K | -$29.48K |
| EPS (Diluted) | -$0.00 | $0.00 |
Margins
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Gross Margin | 78.8% | 40.4% |
| Operating Margin | -322.6% | 0.94% |
| Profit Margin | -416.8% | 0.51% |
| EBITDA Margin | -322.6% | 3.48% |
Returns
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Return on Assets (ROA) | -6272.5% | -3.47% |
Growth
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -64.1% | 4.26% |
Balance sheet
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $90 | $5.43M |
| Total Debt | $264.09K | $85.44M |
| Net Cash (Debt) | -$264.00K | $17.62K |
| Net Cash Per Share | -$0.00 | $0.00 |
| Equity (Book Value) | -$1.47M | $10.50M |
| Book Value Per Share | -$0.00 | $0.60 |
| Tangible Book Value | -$1.47M | -$78.36K |
| Working Capital | -$1.22M | $2.78M |
Financial position
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Current Ratio | 0.00 | 1.26 |
| Quick Ratio | 0.00 | 0.65 |
| Interest Coverage | -2.68 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Operating Cash Flow | -$268.11K | $8.04K |
Efficiency
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Asset Turnover | 15.05 | 0.83 |
| Revenue Per Employee | $61.81K | $216.23K |
| Profits Per Employee | -$257.64K | -$1.99K |
| Employee Count | 2 | 115 |
Dividends and yields
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Earnings Yield | -22.2% | -1.29% |
Shares
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Shares Outstanding | 11,626,700,000 | 29,217,800 |
| Shares Change (YoY) | 9.58% | 0.84% |
| Shares Change (QoQ) | 0.00% | 0.00% |
| Float | 11,626,700,000 | 26,226,050 |
| Shares Held by Insiders | 0.00% | 4.85% |
Scores
| Measure | Cannabis Bioscience International | Industry median |
|---|---|---|
| Altman Z-Score | -7327.20 | 2.64 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Cannabis Bioscience International's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.